have attracted considerable interest as COVID-19 vaccines. In December 2020, Pfizer-BioNTech and Moderna obtained authorization for their mRNA-based COVID-19 vaccines. On 2 December, the UK Medicines and Healthcare products Regulatory Agency (MHRA) became the first medicines regulator